Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxis in Iwate, Japan (1981-1992) and epidemiological evidence for its efficacy

Hepatology Research

Volumn 26, Issue 4, 2003, Pages 287-292

  Koyama, Tomiko ^a   Matsuda, Isao ^b   Sato, Shunichi ^c   Yoshizawa, Hiroshi ^d  

^a Health Service Association   (Japan)

^b Morioka Red Cross Hospital   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Hepatitis B virus; Immunoprophylaxis; Perinatal transmission

Indexed keywords

B MUGEN; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS E ANTIGEN; IMMUNOLOGICAL ADJUVANT; RECOMBINANT VACCINE;

ACTIVE IMMUNIZATION; ANTIBODY TITER; ARTICLE; BABY; CHILD; DRUG EFFICACY; EPIDEMIOLOGY; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; JAPAN; MOTHER; PASSIVE IMMUNIZATION; PERINATAL INFECTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VIRUS CARRIER; VIRUS TRANSMISSION;

EID: 0141838644     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(03)00168-2     Document Type: Article

References (24)

1. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976;294:746-9.
2. Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 1979;3:237-41.
3. Shiraki K, Yoshihara N, Sakurai M, Eto T, Kawana T. Acute hepatitis B in infants born to carrier mother with the antibody to hepatitis B e antigen. J Pediatr 1980;97:768-70.
4. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-45.
5. Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut 1996;38:S39-42.
6. Yoshizawa H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 2002;62:8-17.
7. Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994;170:1418-23.
8. Larouze B, Saimot G, Lustbader ED, London WT, Werner BG, Payet M. Host responses to hepatitis B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal. West Afr Lancet 1976;2:534-8.
9. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet 1981;2:1129-33.
10. Kew MC, Fujita Y, Takahashi H, Coppins A, Wands JR. Comparison between polyclonal and first and second generation monoclonal radioimmunoassays in the detection of hepatitis B surface antigen in patients with hepatocellular carcinoma. Hepatology 1986;6:636-9.
11. Tada H, Yanagida M, Mishina J, et al. Combined passive and active immunization for preventing perinatal transmission of hepatitis B virus carrier state. Pediatrics 1982;70:613-9.
12. Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099-102.
13. Beasley RP, Hwang LY, Stevens CE, et al. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology 1983;3:135-41.
14. Wong VC, Ip HM, Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin: double-blind randomised placebo-controlled study. Lancet 1984;1:921-6.
15. Lo KJ, Tsai YT, Lee SD, et al. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan. Hepatogastroenterology 1985;32:65-8.
16. Esteban JI, Genesca J, Esteban R, et al. Immunoprophylaxis of perinatal transmission of the hepatitis B virus: efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low-prevalence area. J Med Virol 1986;18:381-91.
17. Stevens CE, Taylor PE, Tong MJ, et al. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. J Am Med Assoc 1987;257:2612-6.
18. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children: Taiwan Childhood Hepatoma. Study Group. N Engl J Med 1997;336:1855-9.
19. Marshall E. A shadow falls on hepatitis B vaccination effort. Science 1998;281:630-1.
20. Shimizu H, Mitsuda T, Fujita S, Yokota S. Perinatal hepatitis B virus infection caused by antihepatitis Be positive maternal mononuclear cells. Arch Dis Child 1991;66:718-21.
21. Crawford NG, Pruss AM. Preventing neonatal hepatitis B infection during the perinatal period. J Obstet Gynecol Neonatal Nurs 1993;22:491-7.
22. Prevention of perinatal hepatitis B through enhanced case management - Connecticut, 1994-1995, and the United States, 1994, MMWR Morb. Mortal. Wkly. Rep. 1996;45:584-7.
23. Kohn MA, Farley TA, Scott C. The need for more aggressive follow-up of children born to hepatitis B surface antigen-positive mothers: lessons from the Louisiana Perinatal Hepatitis B Immunization Program. Pediatr Infect Dis J 1996;15:535-40.
24. Program to prevent perinatal hepatitis B virus transmission in a health-maintenance organization - Northern California, 1990-1995, MMWR Morb. Mortal. Wkly. Rep. 1997;46:378-80.